Affiliation:
1. Department of Biotechnology, School of Engineering and Technology, Sharda University, New Delhi, India
2. Complex Systems Division, Beijing Computational Science Research Center, Beijing 100193, China
Abstract
Background:
Allergic diseases are turning into an expanding occurrence around the globe,
imposing a socioeconomic burden, causing grimness and even death. Allergen encounter initiates the
influx of TH2 cells, triggering the production of TH2 associated cytokines (IL-4, IL-5, and IL-13), which
in turn promotes the detrimental allergic inflammation associated with asthma, allergic rhinitis, food
allergy, urticaria, atopic eczema, and anaphylaxis. Cytokine alarmins (TSLP and IL-33) produced by
epithelial cells play important roles in the promotion of TH2 cell development and the initiation of allergic
pathogenesis.
Objectives:
To target cytokine alarmins (TSLP and IL-33) as novel therapeutic proteins, using natural
compounds as a potential cure at an early stage of allergic diseases.
Methods:
Structure-based virtual screening of two large natural compounds databases (Universal Natural
product Database (UNPD) and ZINC natural product database) was conducted for the identification
of TSLP and IL-33 inhibitors using Autodock Vina followed by rescoring of the hit compounds. using
Autodock 4.2 software. In silico physicochemical, pharmacokinetic, and toxicity analyses were conducted
to assess the drug-like properties of the hit compounds. The binding mode stability of
UNPD116849, ZINC01448143, and ZINC04096134 in the binding pocket of TSLP and IL-33 was
probed by all-atom 50 ns molecular dynamics simulation.
Results:
Five natural compounds (UNPD111, UNPD116849, ZINC01448143, ZINC15957528, and
ZINC04096134) containing different structural moieties (steroidal, chromone, benzodioxole, and indole)
were identified to inhibit TSLP and IL-33, with limonin (ZINC04096134) found to demonstrate
dual inhibitory activity potential. These compounds were found to be drug-like and toxicity-free using
in silico Absorption, Distribution, Metabolism, Elimination, and Toxicity (ADME-T) prediction methods.
Taken together, this study suggests the dual inhibition potential of limonin (ZINC04096134)
against the cytokine alarmins.
Conclusion:
Five natural compounds with diverse structural moieties (steroidal, chromone, benzodioxole,
and indole) were virtually identified as hit compounds against cytokine alarmins (TSLP and IL-33),
with limonin showing dual inhibitory potential.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine